The Link Between Valsartan and Cancer
Patients who used Valsartan before its recall in 2018 may face a higher risk of developing certain cancers, including colon cancer. This increased risk has been linked to exposure to N-nitrosodimethylamine (NDMA), a carcinogenic compound found in contaminated batches of the drug. At Conley Griggs Partin LLP, we are committed to helping patients in Atlanta and South Georgia understand their legal options. If you or a loved one has been diagnosed with cancer after taking Valsartan, you may be entitled to file a defective drug lawsuit.
What Led to the Recall of Valsartan?
In July 2018, the U.S. Food and Drug Administration (FDA) issued a recall of several pharmaceutical products containing Valsartan. The recall was prompted by the discovery that these drugs contained NDMA, a known carcinogen. Valsartan, an active ingredient used in medications to treat high blood pressure and heart failure, was found to have impurities introduced during the manufacturing process.
The contaminated Valsartan was traced back to Zhejiang Huahai Pharmaceutical, a supplier based in China. This manufacturer provided Valsartan to multiple pharmaceutical companies in the U.S., including Major Pharmaceuticals, Solco Healthcare, and Teva Pharmaceuticals Industries Ltd. Patients taking these drugs were unknowingly exposed to dangerous levels of NDMA, putting them at risk for serious health complications.
What Is NDMA and How Does It Affect Health?
N-nitrosodimethylamine (NDMA) is a highly toxic organic compound classified as a probable human carcinogen by the International Agency for Research on Cancer (IARC). It is considered a universal carcinogen, meaning it has the potential to cause cancer in various organs. Studies have demonstrated that prolonged exposure to NDMA can lead to cancerous tumors, particularly in the colon, liver, kidneys, and lungs.
Because of these risks, the presence of NDMA in pharmaceuticals like Valsartan is particularly alarming. Patients who relied on these medications to manage their hypertension or heart failure were unknowingly exposed to a significant health hazard. While the FDA has recalled affected products, individuals already diagnosed with cancer after using these drugs may face life-altering consequences.
Are You at Risk?
If you took Valsartan and have since been diagnosed with cancer, particularly colon, liver, kidney, or lung cancer, you may be at risk due to NDMA exposure. Common symptoms of these cancers can include:
- Abdominal pain and unexplained weight loss
- Changes in bowel habits or blood in the stool (for colon cancer)
- Fatigue and jaundice (for liver cancer)
- Persistent cough or shortness of breath (for lung cancer)
Early detection and treatment are critical. If you have concerns about your health, consult with your doctor immediately.
Legal Options for Victims of Defective Valsartan Drugs
Patients who have developed cancer after taking contaminated Valsartan may be eligible to file a defective drug lawsuit. At Conley Griggs Partin LLP, we can help you seek compensation for medical expenses, lost wages, pain and suffering, and other damages. Pharmaceutical companies have a legal responsibility to ensure that their products are safe for consumers. When contamination or negligence occurs, these companies should be held accountable.
Our experienced legal team will investigate your case, gather evidence, and build a strong claim on your behalf. We understand how overwhelming it can be to face a cancer diagnosis, and we are here to support you every step of the way. At Conley Griggs Partin LLP, we have a proven track record of fighting for patients harmed by defective drugs and medical products.
Take Action Today
If you or a loved one developed cancer after taking Valsartan, you don’t have to face this challenge alone. Contact Conley Griggs Partin LLP today for a confidential consultation. We serve clients in Atlanta and across South Georgia, providing expert legal guidance to help you pursue justice and fair compensation. Don’t wait—protect your rights and your future by reaching out to us today.
Posted on behalf of
